AstraZeneca

AstraZeneca’s shares rise 5% amid China’s tax probe update

08 Feb 2025

AstraZeneca, a leading global biopharmaceutical company, has recently experienced a notable uptick in its stock performance, attributed to developments in its operations within China. On February 6, 2025, the company's shares rose by approximately 5%, reflecting investor optimism following updates on an ongoing investigation by Chinese authorities. This investigation pertains...

AstraZeneca Withdraws Lung Cancer Drug Application in EU: What It Means for Patients

28 Dec 2024

AstraZeneca Withdraws Application for Lung Cancer Drug in the EU: What You Need to Know In a significant turn of events in the oncology world, AstraZeneca, a global leader in the pharmaceutical industry, recently withdrew its application for the approval of its lung cancer drug in the European Union. This...

AstraZeneca To Invest This Much In Its GITC Expansion In India, Check Figures

05 Jul 2024

The GCC (Global capability center) of British-Swedish drugmaker AstraZeneca is set to invest Rs 250 crore ($30 million) in expanding its Global Innovation and Technology Centre (GITC) in Chennai. This expansion is set to generate 1,300 jobs, with special emphasis on innovation, efficiency enhancement, and streamlining of operations across the...

‘AstraZeneca Accepts Its Covid Vaccine Can Cause Rare Side-Effect’ Before Court

30 Apr 2024

AstraZeneca, a gigantic pharmaceutical company, has finally acknowledged that the Covid vaccine "may, in very rare cases, cause TTS." This acknowledgment was made public in a court document filed in February and submitted to the High Court. Expert testimony would be required to determine causation in each particular case, as...

Advertisement · Scroll to continue